UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000024383
Receipt number R000028070
Scientific Title Evaluation of the blood flow of the reconstructed organs using ICG fluorescence method during esophagectomy (Multi-center study)
Date of disclosure of the study information 2021/12/01
Last modified on 2018/10/11 14:31:30

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of the blood flow of the reconstructed organs using ICG fluorescence method during esophagectomy (Multi-center study)

Acronym

Evaluation of the blood flow of the reconstructed organs using ICG fluorescence method during esophagectomy

Scientific Title

Evaluation of the blood flow of the reconstructed organs using ICG fluorescence method during esophagectomy (Multi-center study)

Scientific Title:Acronym

Evaluation of the blood flow of the reconstructed organs using ICG fluorescence method during esophagectomy

Region

Japan


Condition

Condition

Esophageal cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Using ICG fluorescence technique, we can visualize the well perfusion site of blood for reconstructed organs during esophagectomy. Thus, we can determine the adequate site for anastomosis. The aim of this study is to confirm the reproducibility of this technique with high volume centers of Japan.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

The rate of leakage of anastomosis

Key secondary outcomes

Factors affecting blood flow at the tip of the reconstructed organs


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking


Concealment

Central registration


Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Maneuver

Interventions/Control_1

ICG fluorescence method

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who receive esophageal reconstruction using gastric tube or small bowel or colon.

Key exclusion criteria

Patients who have past history of allergy for ICG

Target sample size

300


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Youichi Kumagai

Organization

Saitama Medical Center

Division name

Department of the digestive tract and general surgery

Zip code


Address

1981 Kamoda, Kawagoe-shi, Saitama, Japan

TEL

049-228-3619

Email

kuma7srg1@gmail.com


Public contact

Name of contact person

1st name
Middle name
Last name Youichi Kumagai

Organization

Saitama Medical Center

Division name

Department of the digestive tract and general surgery

Zip code


Address

1981 Kamoda, Kawagoe-shi, Saitama, Japan

TEL

049-228-3619

Homepage URL


Email

kuma7srg1@gmail.com


Sponsor or person

Institute

Department of the digestive tract and general surgery, Saitama Medical Center

Institute

Department

Personal name



Funding Source

Organization

Department of the digestive tract and general surgery, Saitama Medical Center

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京医科歯科大学 消化管一般外科学、がん・感染症センター都立駒込病院 外科、
太田総合病院付属太田西ノ内病院 外科


Other administrative information

Date of disclosure of the study information

2021 Year 12 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2016 Year 10 Month 01 Day

Date of IRB


Anticipated trial start date

2016 Year 12 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 10 Month 12 Day

Last modified on

2018 Year 10 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028070


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name